SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001493152-23-045942
Filing Date
2023-12-22
Accepted
2023-12-22 16:31:11
Documents
8

Document Format Files

Seq Description Document Type Size
1 forms-3.htm S-3 488614
2 ex4-5.htm EX-4.5 545682
3 ex4-6.htm EX-4.6 582641
4 ex5-1.htm EX-5.1 27585
5 ex23-1.htm EX-23.1 3932
6 CALCULATION OF FILING FEE TABLES ex107.htm EX-FILING FEES 22158
7 forms-3_001.jpg GRAPHIC 3384
8 forms-3_002.jpg GRAPHIC 3077
  Complete submission text file 0001493152-23-045942.txt   1681000
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

IRS No.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
Type: S-3 | Act: 33 | File No.: 333-276250 | Film No.: 231510284
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)